Antimicrobial Resistance Profiling of Coagulase-Negative Staphylococci in a Referral Center in South Italy: A Surveillance Study

1. INTRODUCTION

Staphylococci are non-spore-forming bacteria that are widespread in nature. Various species of Staphylococcus constitute the normal microbiota of humans and animals: they are found on the skin, on the mucous membranes of the upper respiratory tract and in the intestinal tract. The skin is frequently colonized by staphylococci, especially in humid areas: navel, armpits, groin, perineum, face, hands and scalp. The skin, either intact (through hair follicles or sweat ducts) or interrupted by lesions, represents a frequent entrance for staphylococci. Historically, Coagulase-Negative Staphylococci (CoNS) had been considered to be less pathogenic compared to coagulase-positive ones. However, numerous studies have reported that even coagulase-negative species are equally pathogenic [1, 2]. CoNS, as opportunists, are responsible for severe nosocomial and health-care related infections. They are capable of colonizing and infecting humans through different mechanisms, such as adherence, invasion, persistence and evasion of innate and adaptive immunity [3]. S. epidermidis is the most commonly isolated CoNS [4-7], followed by S. hominis [8-10], S. haemolyticus [11, 12] and S. capitis [13-15]. S. lugdunensis and S. saprophyticus are often responsible for septic arthritis [16-19] and uncomplicated urinary tract infections [20], respectively. The role of CoNS as pathogens has been demonstrated in human infections, particularly in patients with implanted devices, immunocompromised subjects and preterm infants. Virulence factors of these microorganisms are poorly defined and it is very difficult to determine the pathogenicity of clinical isolates [1]. Furthermore, several CoNS have shown resistance to different antibiotics and the treatment of infections has become very difficult [21-23]. Among CoNS, S. lugdunensis is the only species susceptible to a wide range of antimicrobials [24]. In addition, there are few recent data in the literature [25-28]. Accordingly, the aim of the present study was to investigate the etiology and the antibiotic-resistance profiles of CoNS isolated from hospital environments in South Italy.

2. MATERIALS AND METHODS

3. RESULTS

4. DISCUSSION

In the last few years, CoNS have emerged as important nosocomial pathogens and are exhibiting increasing virulence and resistance to many antibiotics [34, 35]. In this study, the antibiotic-resistance profiles of CoNS isolated from a hospital environment in South Italy were evaluated. Staphylococcus haemolyticus and Staphylococcus epidermidis were the most prevalent CoNS isolated from clinical samples. In addition, among the CoNS that were found, we observed differences in antimicrobial resistance. The strains did not exhibit any resistance to linezolid, an oxazolidinone antibacterial agent that inhibits protein synthesis [36]. However, in Italy, plasmidic cfr-mediated linezolid resistance has been reported for S. epidermidis [37]. No clinical isolate was resistant to the glycopeptides vancomycin and teicoplanin. The high susceptibility rate against these antibiotics could be due to the preferential use of linezolid by hospital clinicians [38]. The first two cases of glycopeptide-resistant CoNS strains were reported by Wilson et al. and Schwalbe et al. [39, 40]. In a one-year prospective control study conducted in an Italian University Hospital, Tacconelli et al. isolated nineteen strains resistant to teicoplanin and one strain resistant to both teicoplanin and vancomycin from 535 subjects with bacteremia. They verified that previous exposure to beta-lactams and glycopeptides, multiple hospitalizations and the concomitant presence of pneumonia were connected with the development of resistance to these antibiotics [41]. In recent years, a worldwide increase in the number of glycopeptide-resistant CoNS has been reported [42]. Sgarabotto et al. suggested the association synercid/vancomycin against multidrug-resistant CoNS. The combination of the two antibiotics avoids any side effects [43, 44]. Among the β-lactams, the highest resistance rates were observed for ampicillin and penicillin, followed by amoxicillin-clavulanate, and oxacillin. In Italy, Arciola et al. determined the resistance patterns of 15 different species of CoNS isolated from orthopedic implants. The most prevalent species were S. hominis, S. haemolyticus, S. capitis, S. warneri and S. cohnii, with a resistance rate to penicillin between 51% and 66%. S. haemolyticus exhibited high resistance to oxacillin [45]. For the macrolides group, S. haemolyticus, S. epidermidis and S. hominis showed a high rate of erythromycin-resistance [26]. Within the quinolones, resistance to levofloxacin, ciprofloxacin and ofloxacin was found in about 50% of the clinical isolates. Ligozzi et al. demonstrated that norA-like genes played an important role in the resistance of CoNS to fluoroquinolones [46]. Resistance mechanisms to quinolones include mutations of DNA gyrase and topoisomerase IV [47]. Rifampicin is one of the antibiotics of choice for the treatment of joint and bone infections, due to its ability to penetrate staphylococcal biofilm. The use of this antibiotic has been associated with the development of resistant mutants. Therefore, it is usually administered in association with other antibacterial agents [48]. Trimethoprim-sulfamethoxazole exerts a bacteriostatic effect against staphylococci and susceptibility to this antibiotic combination is highly variable [49]. Regarding tetracycline, in our study, 24% of the strains exhibited resistance. The aminoglycoside gentamycin was tested against CoNS, with a resistance rate of 47%. For the lincosamides class, CoNS showed 28% resistance against clindamycin. Our data are consistent with a recent study by De Vecchi et al. [25], where there was a greater antibiotic resistance in S. haemolyticus than in S. capitis and S. warneri. However, it was not possible to compare our results with others obtained in the same geographical area, since any data regarding the frequency of isolation and antibiotic-resistance of coagulase-negative staphylococci in South Italy are available. From our results concerning CoNS resistance, it is possible to state that the antibiotics rifampicin, tetracycline, trimethoprim-sulfamethoxazole and, to a lesser extent, clindamycin could be used with a good success rate. The antibiotics synercid, linezolid, teicoplanin and vancomycin should be used only in cases where the other antimicrobial agents are not effective.

In the present study, the frequency of isolation and the antibiotic-resistance of coagulase-negative staphylococci from the hospital environment were investigated; not a correlation with the different types of infections. Indeed, since CoNS are commonly present in the human skin and mucous membranes, in some cases, they could contaminate clinical specimens [50, 51]. It is well known that the differentiation between a pathogen and a contaminant is based on several clinical and microbiological factors. Accordingly, in the last few years, different clinical studies have provided guidelines to distinguish pathogenic strains from contaminants, to date, clear, definitive guidelines are still lacking [52]. Although the contamination of specimens is clinically relevant, in this context, we focused on the antibiotic-resistance of coagulase-negative staphylococci isolated from hospital samples. Therefore, we found that, among CoNS, S. haemolyticus and S. epidermidis are the most frequently isolated bacteria from clinical specimens in a single center in South Italy.

CONCLUSION

The comparative analysis of antibiotic resistance patterns of different CoNS revealed high resistance levels of these strains to the most common antibiotics used in clinical practice. Furthermore, the role of CoNS in the pathogenesis of infection should be assessed for each patient. Different antibiotics, including penicillins, cephalosporins, macrolides, tetracycline and aminoglycosides, have proven to be ineffective against several CoNS species. Hence, there is a need to find new effective antimicrobial drugs. In conclusion, our study could be viewed as the first step of a wider investigation that significantly contributes to the evaluation of the clinical importance of coagulase-negative staphylococci, in a small area of the South of Italy.

REFERENCES